Aliment Pharmacol Ther. 2009;30(2):154-64.
Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.
제1저자 이은실 · 교신저자 김나영
소속 (1)
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea.
Abstract
BACKGROUND There has been no report on the response to proton pump inhibitor (PPI) therapy and on-demand or the relapse rate of non-erosive reflux disease (NERD) and erosive oesophagitis in Korea.
AIM To compare the risk factors, clinical symptoms and PPI responses between patients with erosive oesophagitis and NERD patients.
METHODS A survey was performed prospectively in the erosive oesophagitis (205 patients) and NERD group (200 patients). Clinical symptoms, risk factors and PPI responses were analysed. On-demand therapy and the relapse rate of GERD symptoms were investigated during a one-year follow-up.
RESULTS BMI > or = 25 (OR 3.0, 95% CI 1.1-8.3), alcohol use (OR 2.9, 95% CI 1.0-8.3), hiatal hernia (OR 5.0, 95% CI 1.2-20) and triglyceride > or =150 mg/dL (OR 4.0, 95% CI 1.7-10) were more common in the erosive oesophagitis group than in the NERD group by multivariate analysis. The ratio of oesophageal to extra-oesophageal symptoms was higher in the erosive oesophagitis group compared with the NERD group (P < 0.001). The PPI response rates at 8 weeks were different (P = 0.02); refractory rates were higher in the NERD group (16.7%) compared with the erosive oesophagitis group (6.0%). However, there was no significant difference between the two groups in on-demand therapy or the relapse rate.
CONCLUSION These results suggest that the underlying pathogenic mechanisms of erosive oesophagitis and NERD are distinct.
그 밖의 정보
- 출판 형태
- Comparative Study, Journal Article
- 저널
- Alimentary pharmacology & therapeutics · eISSN 1365-2036
- 전자 출판
- 2009-04-15
- MeSH
- Adult · Aged · Aged, 80 and over · Anti-Ulcer Agents / therapeutic use · Esophagitis / drug therapy / epidemiology · Female · Gastroesophageal Reflux / drug therapy / epidemiology · Humans · Korea / epidemiology · Male · Middle Aged · Proton Pump Inhibitors / therapeutic use · Risk Factors · Secondary Prevention · Treatment Outcome · Young Adult
- Substances
- Anti-Ulcer Agents · Proton Pump Inhibitors